Pfizer Touts Chantix To Be Safe Even For Mentally Ill Patients
Date: 6th June 2008
Since FDA (Food and Drugs Administration) has highlighted depression and suicide as the main side-effects triggered off by the quit smoking medication chantix, Pfizer Incl., the manufacturer of this smoking cessation medicine, is trying its best to save the reputation of chantix by projecting the medicine as safe and effective for quit smoking enthusiasts. Altogether, it is known that in a press interview, Dr. Martina Flammer, Senior Medical Director at Pfizer Incl. has revealed that chantix is safe even for people with mental illness and suggested that such people should inform the doctor of their medical history and then opt for chantix.
As a part of its campaign to project chantix as safe and effective for people looking forward to induce smoking cessation, Pfizer is getting ready to publish advertisements in the leading newspapers and also thinking of distributing letters to physicians.
However, Pfizer has already conducted a roundtable discussion with the media where the representatives of the company stressed on the fact that chantix is safe and effective for patients. In the discussion, Pfizer representatives also cited study results that clearly show that there is no risk of suicide attempts from chantix. In the meeting, Pfizer representatives tried to clarify that depression, which is considered to be a potent cause of suicidal behavior, is usually common in people looking forward to induce smoking cessation.